orgenesis.com (ORGS) Year-over-year earnings per share growth for the last twelve months
Orgenesis Inc. is scaling its POCare mobile laboratory network for gene therapy through new contracts. Quarterly earnings per share (EPS) growth demonstrates liquidity dynamics, with the value stabilizing at 74.40. However, debt and expansion challenges are weakening its market position. Stability is provided by service deals with pharma behemoths, which is gradually making cash flows more predictable.
Summary analytical data breakdowns for Orgenesis Corporation (ORGS)
- share price and expert price forecast:
- market capitalization details:
- book capitalization data:
- debt and solvency information:
Total Debt to Capital Orgenesis Inc.|ORGS - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Orgenesis Inc.|ORGS - Company Total Debt Obligations|Debt to Book Value Orgenesis Corp|ORGS - Company Long-Term Loans and Borrowings|Company Short-Term Debts Orgenesis|Quick Liquidity orgenesis.com
- earnings and valuation multiples indicators:
ORGS - Company Profit|Projected Future Earnings Orgenesis Inc.|ORGS - Price to Earnings Ratio|Projected Price to Earnings Orgenesis Corp|ORGS - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Orgenesis Corp|ORGS - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Orgenesis|ORGS - Earnings per share for the trailing year|Quarterly EPS earnings growth orgenesis.com|ORGS - Net earnings per share change in current year|Net earnings per share growth forecast for next year Orgenesis Inc.
Analysis of all company metrics:Orgenesis, ORGS
The decentralized model of Orgenesis Inc. (ORGS) for optimizing cell therapy logistics enables the generation of high licensing revenues, directly impacting the business's net return. The dynamics of these inflows are reflected in the calculation of quarterly earnings per share (EPS) growth, which measures the capitalization efficiency of each ownership stake, allowing a quarterly EPS chart to timely identify financial stability or manipulation risks.
Who Orgenesis Inc. competes with
VEEV: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Doximity Inc (DOCS)|Year-over-year earnings per share growth for the last twelve months HealthEquity Corp|Year-over-year earnings per share growth for the last 12 months WAY (Waystar Corp)|Quarterly EPS earnings growth CRVL|PRVA - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Huron HURN|Year-over-year net earnings per share change for the last twelve months Certara Inc (CERT)|Omnicell Corp - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months GoodRx Gold GDRX|Schrodinger, Inc. (SDGR) - Year-over-year earnings per share growth for the last twelve months|PHR - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months OMDA|EVH: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth HSTM|Year-over-year net earnings per share change for the last twelve months Definitive Corp|Year-over-year earnings per share growth for the last twelve months Consensus Cloud Solutions CCSI|AGL: Year-over-year earnings per share growth for the last 12 months|Absci Corporation - Quarterly EPS earnings growth|So-Young International Inc (SY) - Year-over-year net earnings per share growth for the last 12 months|NRC (National Research Corp) - Year-over-year net earnings per share growth for the last 12 months|SPOK - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months OptimizeRx Corporation|Earnings per share growth in annualized terms for the last twelve months trubridge.com TBRG|Year-over-year earnings per share growth for the last twelve months Simulations Plus (SLP)|SOPH (sophiagenetics.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth HCAT (Health Catalyst, Inc)|Net earnings per share growth for the trailing year CareCloud Inc.|RSSS - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months DLH Holdings Corp. DLHC|ONMD: Quarterly EPS earnings growth|SCNX - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months HCTI|ISPC (iSpecimen Corp) - Year-over-year earnings per share growth rate for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BFRG (Bullfrog AI Holdings)|WORX (scworx.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months MSP Recovery MSPR|ICCT - Year-over-year net earnings per share growth for the last 12 months|TRxADE - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months R1 RCM Inc.|SHCR: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months STRM|Year-over-year earnings per share growth for the last twelve months Syra Health|Earnings per share growth in annualized terms for the last twelve months ApolloMed AMEH|Year-over-year earnings per share growth for the last twelve months Model N Corp (MODN)|NXGN (NextGen Healthcare Corp) - Year-over-year earnings per one share growth for the last 12 months
